High tissue-sodium associates with systemic inflammation and insulin resistance in obese individuals
Ertuglu L, Sahinoz M, Alsouqi A, et al.
NMCD. Pub. online 10 Apr 2023.
Leggi
Breaking news
Diagnosis and management of prediabetes: a review
Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S
JAMA. 2023;329(14):1206-1216.
Leggi
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial
Laugesen C, Ranjan AG, Schmidt S, Nørgaard K
Diabetologia. Pub. online 11 Apr 2023.
Leggi
Efficacy and safety of once‐weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: the AMPLITUDE‐D, AMPLITUDE‐L and AMPLITUDE‐S randomised controlled trials
Aroda VR, Frias JP, Ji L, et al.
Diabetes Obes Metab. Pub. online 4 Apr 2023.
Leggi
Does chronic low-dose aspirin use benefit bone health? A cross-sectional study on patients with type 2 diabetes mellitus
Zhang L, Ji X, Chen J, et al.
BMC Endocr Disord. 2023;23(1):79.
Leggi
Safety and efficacy of an adaptive bolus calculator for type 1 diabetes: a randomised control cross over study
Unsworth R, Armiger R, Jugnee N, et al.
Diabetes Technol Ther. Pub. online 5 Apr 2023.
Leggi
Advanced lipoprotein profile identifies atherosclerosis better than conventional lipids in type 1 diabetes at high cardiovascular risk
Serés-Noriega T, Ortega E, Giménez M, et al.
NMCD. Pub. online 4 Apr 2023.
Leggi
Bergenstal RM, Hachmann-Nielsen E, Kvist K, et al. Diabetes Technol Ther. Pub. online 5 Apr 2023.
Bergenstal RM, Hachmann-Nielsen E, Kvist K, et al.
Diabetes Technol Ther. Pub. online 5 Apr 2023.
Leggi
Low-density lipoprotein cholesterol is predominantly associated with atherosclerotic cardiovascular disease events in patients with evidence of coronary atherosclerosis: the western denmark heart registry
Mortensen MB, Dzaye O, Bøtker HE, et al.
Circulation. 2023;147(14):1053-1063.
Leggi
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: integrated analysis from the CANVAS Program and CREDENCE trial
Yi TW, Wong MMY, Neuen BL, et al.
Diabetes Obes Metab. Pub. online 27 Mar 2023.
Leggi